Bolt Biotherapeutics (BOLT) Research & Development (2020 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Research & Development for 6 consecutive years, with $5.0 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 57.45% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.5 million through Dec 2025, down 50.35% year-over-year, with the annual reading at $28.5 million for FY2025, 50.35% down from the prior year.
- Research & Development hit $5.0 million in Q4 2025 for Bolt Biotherapeutics, down from $6.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $22.5 million in Q4 2021 to a low of $5.0 million in Q4 2025.
- Historically, Research & Development has averaged $14.8 million across 5 years, with a median of $15.5 million in 2023.
- Biggest five-year swings in Research & Development: surged 115.0% in 2021 and later tumbled 57.45% in 2025.
- Year by year, Research & Development stood at $22.5 million in 2021, then fell by 25.08% to $16.8 million in 2022, then fell by 3.1% to $16.3 million in 2023, then decreased by 28.18% to $11.7 million in 2024, then crashed by 57.45% to $5.0 million in 2025.
- Business Quant data shows Research & Development for BOLT at $5.0 million in Q4 2025, $6.5 million in Q3 2025, and $7.5 million in Q2 2025.